Status:
COMPLETED
Lung Cancer Screening: A Multilevel Intervention
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Tobacco Related Disease Research Program
Conditions:
Lung Cancer
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
The study will develop and test the feasibility of the Lung Cancer Assessment of Risk and Education (LungCARE) intervention to increase discussions about lung cancer screening between patients and phy...
Eligibility Criteria
Inclusion
- age 55-80
- smoked at least 30 pack-years in lifetime
- if former smoker, quit smoking within the last 15 years
- English speaker
- no prior history of lung cancer
- did not have a lung cancer screening test within the last year
- PCP does not object to patient's participation
- have a scheduled visit at University of California, San Francisco (UCSF) internal medicine clinics.
Exclusion
- speaking a language other than English
- has a history of lung cancer
- had a lung cancer screening test within the last year
- PCP objects to patient's participation.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03862001
Start Date
March 1 2019
End Date
March 30 2020
Last Update
October 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143